Literature DB >> 20016394

Characteristics of children with Shigella encephalopathy: experience from a large urban diarrhea treatment center in Bangladesh.

Mohammod Jobayer Chisti1, Abu Syed Golam Faruque, Wasif Ali Khan, Sumon Kumar Das, Mir Borhan Zabed, Mohammed Abdus Salam.   

Abstract

BACKGROUND: Encephalopathy is a serious neurologic complication from shigellosis often with fatal outcome but data on simple clinical and sociodemographic predicting factors are limited. We sought to identify those factors in children.
METHODS: In this unmatched case-control design, children of both sexes, aged 0 to 15 years having positive stool culture for Shigella from 1997 to 2006 were studied. Children with Shigella encephalopathy constituted the cases (n = 29), whereas randomly selected children with shigellosis having no encephalopathy constituted controls (n = 87).
RESULTS: The case-fatality was significantly higher among the cases than among controls (7% vs. 0%, RR: 4.2, CI: 3.0-5.9, P = 0.013). In logistic regression analysis, children with Shigella encephalopathy more often had an illiterate father (OR: 5.4, 95% CI: 1.1-27.1, P = 0.038), stopped breast-feeding in the neonatal period (OR: 41.3, 95% CI: 4.2-403.1, P = 0.001), had dehydrating diarrhea (OR: 9.9, 95% CI: 2.1-45.9, P = 0.004) with a duration of <1 day (OR: 29.4, 95% CI: 2.1-43.2, P = 0.004), and were more likely to be severely stunted (OR: 6.4, 95% CI: 1.2-34.9, P = 0.033).
CONCLUSION: Education of parents about the value of exclusive breast-feeding and of prompt hydration in children with Shigella is critical to minimize morbidity and deaths.

Entities:  

Mesh:

Year:  2010        PMID: 20016394     DOI: 10.1097/INF.0b013e3181cb4608

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Bacterial enteropathogens and risk factors associated with childhood diarrhea.

Authors:  Abdel Moati Kh Al Jarousha; Mahmoud A El Jarou; Iyad A El Qouqa
Journal:  Indian J Pediatr       Date:  2010-10-06       Impact factor: 1.967

Review 2.  Shigella flexneri: an emerging pathogen.

Authors:  Iqbal Nisa; Muhammad Qasim; Nusrat Yasin; Rafi Ullah; Anwar Ali
Journal:  Folia Microbiol (Praha)       Date:  2020-02-05       Impact factor: 2.099

Review 3.  Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas.

Authors:  Margaret Kosek; Pablo Peñataro Yori; Maribel Paredes Olortegui
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

4.  Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children.

Authors:  P B Pavlinac; D M Denno; G C John-Stewart; F M Onchiri; J M Naulikha; E A Odundo; C E Hulseberg; B O Singa; L E Manhart; J L Walson
Journal:  J Pediatric Infect Dis Soc       Date:  2015-07-12       Impact factor: 3.164

5.  Impact of lack of breast feeding during neonatal age on the development of clinical signs of pneumonia and hypoxemia in young infants with diarrhea.

Authors:  Mohammod J Chisti; Mohammed A Salam; Jonathan Harvey Smith; Tahmeed Ahmed; Hasan Ashraf; Pradip K Bardhan; Mark A C Pietroni
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

6.  Risk factors and outcome of Shigella encephalopathy in Bangladeshi children.

Authors:  Farzana Afroze; Tahmeed Ahmed; Monira Sarmin; Abu Smsb Shahid; K M Shahunja; Lubaba Shahrin; Mohammod Jobayer Chisti
Journal:  PLoS Negl Trop Dis       Date:  2017-04-28

7.  Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic.

Authors:  Wasif A Khan; Jeffrey K Griffiths; Michael L Bennish
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

8.  Associated factors, post infection child growth, and household cost of invasive enteritis among under 5 children in Bangladesh.

Authors:  Rina Das; Md Ahshanul Haque; Mohammod Jobayer Chisti; A S G Faruque; Tahmeed Ahmed
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.